查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1518271

2024 年臨床試驗影像全球市場報告

Clinical Trial Imaging Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

臨床試驗成像市場規模預計在未來幾年將強勁成長。 2028年，這一數字將以9.4%的複合年成長率成長至20.7億美元。預測期內的預期成長是由多種因素造成的。其中包括慢性病的增加、研發成本的增加、老年人口的增加、臨床研究數量的擴大以及委外研發機構數量的增加。預測期內預期的主要趨勢包括增強診斷成像模式的技術進步、市場參與者擴大能力和產品供應的策略性舉措、在藥物開發中採用基於成像的方法；其中包括分子成像和人工智慧主導分析的進步；持續的產品創新等等。

慢性病盛行率的增加預計將在未來幾年推動臨床試驗影像市場的成長。慢性病的特徵是需要持續治療的長期病症，並且由於接觸污染物、生活方式改變和遺傳傾向等因素而變得越來越常見。臨床試驗影像在透過影像技術有效監測這些病症、幫助患者了解其疾病及其對治療的影響，從而提高依從性和滿意度方面發揮著重要作用。例如，國家醫學圖書館2021年5月發布的預測表明，到2040年，全球癌症負擔將大幅增加，導致病例和死亡人數大幅增加。此外，美國美國生物技術資訊中心 2023 年 1 月的資料顯示，美國2023 年預計新增癌症病例和死亡人數很高。這清楚地表明了慢性病的流行如何推動了對臨床試驗成像技術進步的需求。

臨床試驗成像市場的主要企業正在專注於開發雲端基礎的成像工具，以提供改進的解決方案並提高臨床試驗的效率。這些工具利用雲端運算技術來儲存、管理和分析醫學影像。例如，2023 年 3 月，美國先進配電系統製造商 Clarion 宣布推出一款創新的雲端基礎的影像檢視器工具。該工具可讓您根據需要即時查看和操作高解析度影像，無需手動干預即可提供讀取品質的存取。該工具簡化了影像檢視過程，並確保簡單、安全和合規的資料可存取性，使用戶能夠獲得對臨床實驗對象的寶貴見解。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球臨床試驗影像市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球臨床試驗影像市場表現：規模與成長，2018-2023
  • 全球臨床試驗影像市場預測：規模與成長，2023-2028，2033F

第6章 市場細分

  • 全球臨床試驗影像市場：按產品和服務分類的績效和預測，2018-2023、2023-2028F、2033F
  • 服務
  • 軟體
  • 全球臨床試驗影像市場：依模式分類的表現與預測，2018-2023、2023-2028F、2033F
  • CT檢查
  • 磁振造影
  • 心臟超音波圖
  • 核子醫學
  • 正子斷層掃描
  • X光
  • 超音波
  • 光學同調斷層掃描
  • 其他方式
  • 全球臨床試驗影像市場：按應用分類的表現與預測，2018-2023、2023-2028F、2033F
  • 腫瘤學
  • 神經病學
  • 心臟病學
  • 內分泌學
  • 皮膚科
  • 血液學
  • 其他用途
  • 全球臨床試驗影像市場：依供應商分類的績效與預測，2018-2023、2023-2028F、2033F
  • 直銷
  • 競標銷售
  • 全球臨床試驗影像市場：最終使用者的表現與預測，2018-2023、2023-2028F、2033F
  • 受託研究機構
  • 製藥和生物技術公司
  • 醫療設備製造商
  • 學術和政府研究機構
  • 其他最終用戶

第 7 章 區域/國家分析

  • 全球臨床試驗影像市場：按地區分類的表現和預測，2018-2023、2023-2028F、2033F
  • 全球臨床試驗影像市場：按國家分類的表現和預測，2018-2023、2023-2028F、2033F

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 臨床試驗影像市場：競爭格局
  • 臨床試驗影像市場：公司簡介
    • Koninklijke Philips NV
    • Labcorp Drug Development
    • Icon Plc
    • PPD Inc.
    • Syneos Health

第31章 其他大型創新企業

  • Charles River Laboratories
  • Parexel International Corporation
  • Clario
  • Medpace Inc.
  • Medidata Solution Inc.
  • Biotelemetry Inc.
  • WIRB-Copernicus Group
  • ProScan Imaging LLC
  • Invicro LLC
  • Perspectum
  • Radiant Sage LLC
  • Worldcare Clinical LLC
  • Intrinsic Imaging LLC
  • Datatrak Inc.
  • IXICO Plc

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18316

Clinical trial imaging involves utilizing medical imaging techniques such as magnetic resonance imaging (MRI), computed tomography (CT) scans, and X-rays to capture detailed internal images of participants during clinical trials. These images play a vital role in monitoring disease progression, evaluating treatment efficacy, and ensuring patient safety, making it an essential component in assessing the biological impact of new therapies and interventions.

The primary products and services in clinical trial imaging include services and software. Clinical trial imaging services entail providing specialized imaging techniques and methodologies to support the research and development phases of clinical trials. Various modalities encompass computed tomography, magnetic resonance imaging, echocardiography, nuclear medicine, positron emission tomography, X-ray, ultrasound, optical coherence tomography, among others. These services cater to various applications such as oncology, neurology, cardiology, endocrinology, dermatology, hematology, and others, distributed through direct sales and tender sales. End-users include contract research organizations, pharmaceutical and biotechnology companies, medical device manufacturers, academic and government research institutes, among others.

The clinical trial imaging market research report is one of a series of new reports from The Business Research Company that provides clinical trial imaging market statistics, including clinical trial imaging industry global market size, regional shares, competitors with a clinical trial imaging market share, detailed clinical trial imaging market segments, market trends, and opportunities, and any further data you may need to thrive in the clinical trial imaging industry. This clinical trial imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical trial imaging market size has grown strongly in recent years. It will grow from $1.32 billion in 2023 to $1.44 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The expansion observed in the historical period can be attributed to several factors. These include increased sales and distribution of clinical imaging software and services, heightened awareness of breast cancer risks, rising healthcare spending, which leads to improved infrastructure, and increased research and development investments by pharmaceutical and biotechnological companies.

The clinical trial imaging market size is expected to see strong growth in the next few years. It will grow to $2.07 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The anticipated growth in the forecast period can be attributed to several factors. These include the increasing prevalence of chronic diseases, rising expenditures on research and development, a growing geriatric population, an expanding number of clinical studies, and a rise in the number of contract research organizations. Major trends expected in the forecast period encompass technological advancements that enhance imaging modalities, strategic initiatives by market players to expand capabilities and offerings, the adoption of imaging-based approaches in drug development, advancements in molecular imaging and AI-driven analysis, and ongoing product innovation.

The increasing prevalence of chronic diseases is expected to drive growth in the clinical trial imaging market in the future. Chronic diseases, characterized by long-lasting conditions requiring ongoing medical attention, are becoming more prevalent due to factors such as exposure to pollutants, lifestyle changes, and genetic predispositions. Clinical trial imaging plays a crucial role in efficiently monitoring these conditions through imaging techniques, aiding patients in understanding their ailments and treatment impacts, thus enhancing adherence and satisfaction. For example, projections from the National Library of Medicine in May 2021 suggest a substantial increase in the global cancer burden by 2040, with a significant rise in cases and deaths. Additionally, data from the National Center for Biotechnology Information in January 2023 indicates a high number of new cancer cases and projected deaths in the United States for 2023. This underscores how the growing prevalence of chronic diseases fuels demand for advancements in clinical trial imaging technologies.

Major players in the clinical trial imaging market are focusing on developing cloud-based imaging tools to offer improved solutions and enhance clinical trial efficiency. These tools leverage cloud computing technology to store, manage, and analyze medical images. For instance, in March 2023, Clarion, a US-based manufacturer of advanced power distribution systems, introduced an innovative cloud-based image viewer tool. This tool enables real-time, on-demand viewing and manipulation of high-resolution images, providing read-quality access without the need for manual steps. It streamlines the image viewing process, ensuring easy, secure, and compliant data accessibility, empowering users to gain valuable insights into trial subjects.

In March 2023, Medica, a UAE-based medical company, acquired RadMD for an undisclosed sum. This strategic acquisition enables Medica to enter the clinical trials market, utilizing RadMD's expertise to enhance cost-efficiency and streamline drug and device development processes for pharmaceutical, biotech, and contract research organizations (CROs). RadMD, based in the US, specializes in offering clinical trial imaging solutions.

Major companies operating in the clinical trial imaging market are Koninklijke Philips N.V., Labcorp Drug Development, Icon Plc, PPD Inc., Syneos Health, Charles River Laboratories, Parexel International Corporation, Clario, Medpace Inc., Medidata Solution Inc., Biotelemetry Inc., WIRB-Copernicus Group, ProScan Imaging LLC, Invicro LLC, Perspectum , Radiant Sage LLC, Worldcare Clinical LLC , Intrinsic Imaging LLC, Datatrak Inc., IXICO Plc, Calyx Inc., Resonance Health Ltd., Anagram-ESIC SL

North America was the largest region in the clinical trial imaging market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical trial imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical trial imaging market consists of revenues earned by entities by providing services such as image protocol development, data management and integration, image processing, and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial imaging market also includes sales of analysis tools, clinical trial management systems, and compliance tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Trial Imaging Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical trial imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical trial imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical trial imaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Services: Services; Software
  • 2) By Modality: Computed Tomography; Magnetic Resonance Imaging; Echocardiography; Nuclear Medicine; Positron Emission Tomography; X-Ray; Ultrasound; Optical Coherence Tomography; Other Modalities
  • 3) By Application: Oncology; Neurology; Cardiology; Endocrinology; Dermatology; Hematology; Other Applications
  • 4) By Distributer: Direct Sales; Tender Sales
  • 5) By End User: Contract Research Organizations; Pharmaceutical And Biotechnology Companies; Medical Device Manufacturers; Academic And Government Research Institutes; Other End-Users
  • Companies Mentioned: Koninklijke Philips N.V.; LabCorp Drug Development; Icon Plc; PPD Inc.; Syneos Health
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Trial Imaging Market Characteristics

3. Clinical Trial Imaging Market Trends And Strategies

4. Clinical Trial Imaging Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Clinical Trial Imaging Market Size and Growth

  • 5.1. Global Clinical Trial Imaging Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Clinical Trial Imaging Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Clinical Trial Imaging Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Clinical Trial Imaging Market Segmentation

  • 6.1. Global Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Services
  • Software
  • 6.2. Global Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Computed Tomography
  • Magnetic Resonance Imaging
  • Echocardiography
  • Nuclear Medicine
  • Positron Emission Tomography
  • X-Ray
  • Ultrasound
  • Optical Coherence Tomography
  • Other Modalities
  • 6.3. Global Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Neurology
  • Cardiology
  • Endocrinology
  • Dermatology
  • Hematology
  • Other Applications
  • 6.4. Global Clinical Trial Imaging Market, Segmentation By Distributer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Direct Sales
  • Tender Sales
  • 6.5. Global Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Contract Research Organizations
  • Pharmaceutical And Biotechnology Companies
  • Medical Device Manufacturers
  • Academic And Government Research Institutes
  • Other End-Users

7. Clinical Trial Imaging Market Regional And Country Analysis

  • 7.1. Global Clinical Trial Imaging Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Clinical Trial Imaging Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Clinical Trial Imaging Market

  • 8.1. Asia-Pacific Clinical Trial Imaging Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Clinical Trial Imaging Market

  • 9.1. China Clinical Trial Imaging Market Overview
  • 9.2. China Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Clinical Trial Imaging Market

  • 10.1. India Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Clinical Trial Imaging Market

  • 11.1. Japan Clinical Trial Imaging Market Overview
  • 11.2. Japan Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Clinical Trial Imaging Market

  • 12.1. Australia Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Clinical Trial Imaging Market

  • 13.1. Indonesia Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Clinical Trial Imaging Market

  • 14.1. South Korea Clinical Trial Imaging Market Overview
  • 14.2. South Korea Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Clinical Trial Imaging Market

  • 15.1. Western Europe Clinical Trial Imaging Market Overview
  • 15.2. Western Europe Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Clinical Trial Imaging Market

  • 16.1. UK Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Clinical Trial Imaging Market

  • 17.1. Germany Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Clinical Trial Imaging Market

  • 18.1. France Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Clinical Trial Imaging Market

  • 19.1. Italy Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Clinical Trial Imaging Market

  • 20.1. Spain Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Clinical Trial Imaging Market

  • 21.1. Eastern Europe Clinical Trial Imaging Market Overview
  • 21.2. Eastern Europe Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Clinical Trial Imaging Market

  • 22.1. Russia Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Clinical Trial Imaging Market

  • 23.1. North America Clinical Trial Imaging Market Overview
  • 23.2. North America Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Clinical Trial Imaging Market

  • 24.1. USA Clinical Trial Imaging Market Overview
  • 24.2. USA Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Clinical Trial Imaging Market

  • 25.1. Canada Clinical Trial Imaging Market Overview
  • 25.2. Canada Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Clinical Trial Imaging Market

  • 26.1. South America Clinical Trial Imaging Market Overview
  • 26.2. South America Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Clinical Trial Imaging Market

  • 27.1. Brazil Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Clinical Trial Imaging Market

  • 28.1. Middle East Clinical Trial Imaging Market Overview
  • 28.2. Middle East Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Clinical Trial Imaging Market

  • 29.1. Africa Clinical Trial Imaging Market Overview
  • 29.2. Africa Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Clinical Trial Imaging Market Competitive Landscape And Company Profiles

  • 30.1. Clinical Trial Imaging Market Competitive Landscape
  • 30.2. Clinical Trial Imaging Market Company Profiles
    • 30.2.1. Koninklijke Philips N.V.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Labcorp Drug Development
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Icon Plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. PPD Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Syneos Health
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Clinical Trial Imaging Market Other Major And Innovative Companies

  • 31.1. Charles River Laboratories
  • 31.2. Parexel International Corporation
  • 31.3. Clario
  • 31.4. Medpace Inc.
  • 31.5. Medidata Solution Inc.
  • 31.6. Biotelemetry Inc.
  • 31.7. WIRB-Copernicus Group
  • 31.8. ProScan Imaging LLC
  • 31.9. Invicro LLC
  • 31.10. Perspectum
  • 31.11. Radiant Sage LLC
  • 31.12. Worldcare Clinical LLC
  • 31.13. Intrinsic Imaging LLC
  • 31.14. Datatrak Inc.
  • 31.15. IXICO Plc

32. Global Clinical Trial Imaging Market Competitive Benchmarking

33. Global Clinical Trial Imaging Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Clinical Trial Imaging Market

35. Clinical Trial Imaging Market Future Outlook and Potential Analysis

  • 35.1 Clinical Trial Imaging Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Clinical Trial Imaging Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Clinical Trial Imaging Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer